奥拉迪约在中国上市了吗？

Berotralstat is a new, oral, once-daily, potent, selective human plasma kallikrein inhibitor that prevents edema attacks by inhibiting kallikrein to prevent the production of bradykinin. (berotralstat) is used to prevent attacks of hereditary angioedema (HAE) in children and adults 12 years of age and older. Oradejo is the first oral nonsteroidal drug to prevent attacks of HAE.

Orladeyo capsules are a plasma kallikrein inhibitor. Berotralstat dihydrochloride is a white to off-white powder that is soluble in water at pH ≤ 4. Orladeyo is available as 150 mg (equivalent to 169.4 mg Berotralstat hydrochloride) and 110 mg (equivalent to 124.2 mg Berotralstat hydrochloride) hard capsules for oral administration. Each capsule contains the active ingredient dihydrochloride and the inactive ingredients colloidal silicon dioxide, crospovidone, magnesium stearate and pregelatinized starch.

Is it listed in China? Currently, Orladeyo is not listed in our country, so it is not eligible for medical insurance. In other words, if patients want to purchase the drug, they must go abroad to purchase it. Traveling abroad to buy medicines is a long journey and requires a lot of manpower and material resources. Coupled with the huge medical expenses, many patient families are overwhelmed. However, as far as Medical Companion Travel currently knows, Oladiyo is more cost-effective than other versions, and it is directly mailed overseas, which is convenient and fast, and 100% authentic. Since the exchange rate has been in a state of fluctuation for a long time, the price fluctuates with the exchange rate and is not static. For more information about Oradieu, please contact Medical Companion Travel for details.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.